Development of new molecules, vectors and cells for therapy of arthritis

Joint Bone Spine

Volumn 70, Issue 6, 2003, Pages 474-476

  Chernajovsky, Yuti ^a   Vessillier, Sandrine ^a   Adams, Gill ^a   Gofur, Yarunessa ^a   Subang, M Cristina ^a   Annenkov, Alex ^a   Favorov, Peter ^a   Daly, Gordon ^a   Gould, David ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cytokines; Dendritic cells; Gene therapy; T cells

Indexed keywords

CYTOKINE; LATENT CYTOKINE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ARTHRITIS; CELL BASED GENE THERAPY; CELL ENGINEERING; CONFERENCE PAPER; DENDRITIC CELL; DNA VECTOR; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; PHARMACOKINETICS; PROTEIN ENGINEERING; PROTEIN TARGETING; PROTEIN THERAPY; PROTEIN TRANSPORT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0347363691     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(03)00157-X     Document Type: Conference Paper

References (20)

1. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med 2000;51:207-29.
2. Robbins P, Evans C, Chernajovsky Y. Gene therapy for arthritis, Gene Ther 2003;10:902-11.
3. Robbins PD, Evans CH, Chernajovsky Y. Gene therapy for rheumatoid arthritis. Springer Semin Immunopathol 1998;20:197-209.
4. Neve R, Kissonerghis M, Clark J, et al. Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist. Cytokine 1996;8:365-70.
5. Chernajovsky Y. Systemic gene therapy for arthritis. Drugs Today 1999;35:361-77.
6. Gould DJ, Berenstein M, Dreja H, et al. A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications. Gene Ther 2000;7:2061-70.
7. Gould D, Bright C, Chernajovsky Y. Inhibition of collagen induced arthritis with dTNF-R expressed from a doxycycline regulative plasmid. Rheumatology 2002;41(S1):29.
8. Croxford JL, Triantaphyllopoulos KA, Neve RM, et al. Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor. J Immunol 2000;164:2776-81.
9. Chernajovsky Y, Adams G, Podhajcer OL, et al. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Ther 1995;2:731-5.
10. Gofur Y, Chernajovsky Y. The development of immunocytokines for the treatment of rheumatoid arthritis. Rheumatology 2002;41(S1):28.
11. Rabinovich GA, Daly G, Dreja H, et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999;190:385-98.
12. Triantaphyllopoulos KA, Williams RO, Tailor H, et al. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy. Arthritis Rheum 1999;42:90-9.
13. Dreja H, Annenkov A, Chernajovsky Y. Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis. Arthritis Rheum 2000;43:1698-709.
14. Dai L, Claxson A, Marklund SL, Feakins RN, Youssaf N, Chernajovsky Y, et al. Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes. Gene Ther 2003;10:550-8.
15. Mageed RA, Adams G, Woodrow D, et al. Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor. Gene Ther 1998;5:1584-92.
16. Chernajovsky Y, Adams G, Triantaphyllopoulos K, et al. Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model. Gene Ther 1997;4:553-9.
17. Annenkov AE, Moyes SP, Eshhar Z, et al. Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and FcεR1-signaling γ subunit. J Immunol 1998;161:6604-13.
18. Annenkov A, Chernajovsky Y. Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR ζ. Gene Ther 2000;7(8): 714-22.
19. Annenkov A, Daly GM, Brocker T, et al. Clustering of ITAM-containing signalling subunits in CD4+ T cells is an optimal signal for IFN-γ production, but not for the production of IL-4. Int Immunol 2003;15:665-77.
20. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995;268:1766-9.